🇺🇸 FDA
Pipeline program

Myocardial perfusion imaging

09-307

Approved other completed

Quick answer

Myocardial perfusion imaging for Coronary Artery Disease is a Approved program (other) at Aspire Biopharma Holdings with 1 ClinicalTrials.gov record(s).

Program details

Company
Aspire Biopharma Holdings
Indication
Coronary Artery Disease
Phase
Approved
Modality
other
Status
completed

Clinical trials